Quanterix Sets Sights on IPO
From concussions and Alzheimer’s to heart attacks, scientists at Quanterix are saying there are clues to diseases in your blood, and the company is hoping to go public with a technology that can find them.
The Lexington diagnostic company has realized $5 million in revenue in the first half of this year, already exceeding what the company produced in 2014 as a whole.
As revenue keeps growing, executives have begun conversations with investors on plotting an IPO.
Help employers find you! Check out all the jobs and post your resume.
The Lexington diagnostic company has realized $5 million in revenue in the first half of this year, already exceeding what the company produced in 2014 as a whole.
As revenue keeps growing, executives have begun conversations with investors on plotting an IPO.
Help employers find you! Check out all the jobs and post your resume.